Recent Blog Articles

Heart-healthy habits for children and teens lengthen lives

Monkeypox: An unfamiliar virus spreading fast — sound familiar?

Diabetes: Does a long-term study reinforce or change approaches to prevention?

War anxiety: How to cope

Can we prevent depression in older adults by treating insomnia?

Want to try veganism? Here's how to get started

Vitamin B6 flies under the radar: Are you getting enough?

The formula shortage is hurting families: What parents should know and do

Gyn Care 101: What to know about seeing a gynecologist

Swimming lessons save lives: What parents should know
Cancer
Focal therapy for prostate cancer?
- By Harvard Prostate Knowledge
Men diagnosed with prostate cancer often face a dilemma when it comes to choosing a treatment. Radiation and surgery are effective in controlling cancer, but most patients subsequently experience sexual difficulties, urological side effects, or both. Active surveillance preserves genitourinary function, but it can cause anxiety. Regular monitoring can also prove burdensome.
Two teams of researchers suggest some middle ground, a treatment that can effectively kill cancer and preserve function. They argue in favor of testing focal therapy, which only treats the tumor and a small margin of normal tissue around it. In contrast, radical therapies target the entire prostate, often damaging surrounding structures.
Candidates for focal therapy might include patients with cancer that’s confined to the prostate and limited in scope (one or two cancerous areas). Few studies of focal therapy have been completed, and those included few patients, used varying techniques, and lacked solid data on adverse effects. But with dramatic improvements in technologies like magnetic resonance imaging, physicians can more precisely map tumors than ever before.
Given the availability of the technology needed to locate and treat cancerous lesions, the researchers conclude that the concept of focal therapy should be investigated.
SOURCES: Ahmed HU, Pendse D, Illing R, et al. Will Focal Therapy Become a Standard of Care for Men with Localized Prostate Disease? Nature Clinical Practice Oncology 2007;4:632–42. PMID: 17965641.
Eggener SE, Scardino PT, Carroll PR, et al. Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities. Journal of Urology 2007;178:2260–67. PMID: 17936815.
Originally published Jan. 1, 2008; last reviewed April 7, 2011.
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
Comments
Commenting has been closed for this post.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!